Assessment of Accuracy of Identification of Pathogenic Yeasts in Microbiology Laboratories in the United Kingdom

被引:17
作者
Borman, Andrew M. [1 ]
Szekely, Adrien [1 ]
Palmer, Michael D. [1 ]
Johnson, Elizabeth M. [1 ]
机构
[1] Hlth Protect Agcy, Mycol Reference Lab, Bristol, Avon, England
关键词
EPIDEMIOLOGIC CUTOFF VALUES; BLOOD-STREAM INFECTION; ANTIFUNGAL SUSCEPTIBILITY; MOLECULAR-IDENTIFICATION; PYROSEQUENCING ANALYSIS; CANDIDA-METAPSILOSIS; NOSOCOMIAL CANDIDA; MIC DISTRIBUTIONS; VORICONAZOLE; SURVEILLANCE;
D O I
10.1128/JCM.00913-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rapid, accurate identification of yeast isolates from clinical samples has always been important given their innately variable antifungal susceptibility profiles. Recently, this has become paramount with the proposed introduction of species-specific interpretive breakpoints for MICs obtained in yeast antifungal susceptibility tests (M.A. Pfaller, D. Andes, D.J. Diekema, A. Espinel-Ingroff, D. Sheehan, and CLSI Subcommittee for Antifungal Susceptibility Testing, Drug Resist. Updat. 13:180-195, 2010). Here, we present the results of a 12-month evaluation of the accuracy of identifications that accompany yeast isolates submitted to the Mycology Reference Laboratory (United Kingdom) for either confirmation of identity or susceptibility testing. In total, 1,781 yeast isolates were analyzed, and the robustness of prior identifications obtained in microbiology laboratories throughout the United Kingdom was assessed using a combination of culture on chromogenic agar, morphology on cornmeal agar, and molecular identification by pyrosequencing. Over 40% of isolates (755) were submitted without any suggested identification. Of those isolates with a prior identification, 100 (9.7%) were incorrectly identified. Error rates ranged from 5.2% (for organisms submitted for antifungal susceptibility testing) to 18.2% (for organisms requiring confirmation of identity) and varied in a strictly species-specific manner. At least 50% of identification errors would be likely to affect interpretation of MIC data, with a possible impact on patient management. In addition, 2.3% of submitted cultures were found to contain mixtures of at least two yeast species. The vast majority of mixtures had gone undetected in the referring laboratory and would have impacted the interpretation of antifungal susceptibility profiles and patient management. Some of the more common misidentifications are discussed according to the identification method employed, with suggestions for avoiding such misinterpretations.
引用
收藏
页码:2639 / 2644
页数:6
相关论文
共 37 条
  • [1] Does one voriconazole breakpoint suit all Candida species?
    Arendrup, Maiken Cavling
    Denning, David W.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (06) : 2093 - 2093
  • [2] Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media
    Arendrup, Maiken Cavling
    Garcia-Effron, Guillermo
    Lass-Floerl, Cornelia
    Gomez Lopez, Alicia
    Rodriguez-Tudela, Juan-Luis
    Cuenca-Estrella, Manuel
    Perlin, David S.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 426 - 439
  • [3] Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species
    Arendrup, Maiken Cavling
    Kahlmeter, Gunnar
    Luis Rodriguez-Tudela, Juan
    Donnelly, J. Peter
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1628 - 1629
  • [4] Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents
    Borman, Andrew M.
    Petch, Rebecca
    Linton, Christopher J.
    Palmer, Michael D.
    Bridge, Paul D.
    Johnson, Elizabeth M.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (03) : 933 - 938
  • [5] Rapid Molecular Identification of Pathogenic Yeasts by Pyrosequencing Analysis of 35 Nucleotides of Internal Transcribed Spacer 2
    Borman, Andrew M.
    Linton, Christopher J.
    Oliver, Debra
    Palmer, Michael D.
    Szekely, Adrien
    Johnson, Elizabeth M.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (10) : 3648 - 3653
  • [6] Pyrosequencing Analysis of 20 Nucleotides of Internal Transcribed Spacer 2 Discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis
    Borman, Andrew M.
    Linton, Christopher J.
    Oliver, Debra
    Palmer, Michael D.
    Szekely, Adrien
    Odds, Frank C.
    Johnson, Elizabeth M.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2307 - 2310
  • [7] Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens
    Campbell, CK
    Davey, KG
    Holmes, AD
    Szekely, A
    Warnock, DW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) : 821 - 823
  • [8] Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans
    Campbell, CK
    Holmes, AD
    Davey, KG
    Szekely, A
    Warnock, DW
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (05) : 367 - 368
  • [9] Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii)
    Desnos-Ollivier, Marie
    Ragon, Marie
    Robert, Vincent
    Raoux, Dorothee
    Gantier, Jean-Charles
    Dromer, Francoise
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (10) : 3237 - 3242
  • [10] Yeast identification in the clinical microbiology accepted 15 August 2000 laboratory: phenotypical methods
    Freydiere, AM
    Guinet, R
    Boiron, P
    [J]. MEDICAL MYCOLOGY, 2001, 39 (01) : 9 - 33